Investing in Women: A Look at NASDAQ's Women-Focused Product Companies

Wishing you a happy International Women’s Day. If you are looking to invest in companies that prioritize women’s needs and interests, you’ve come to the right place. In this post, we’ll take a closer look at some of the top women-focused product companies listed on NASDAQ.

In recent years, we’ve seen a growing number of companies that are dedicated to serving women and their unique needs and experiences. It is also worth mentioning that many of these companies are listed on the NASDAQ exchange, so investors have the chance to take advantage of exciting opportunities. Whether it’s online marketplaces for luxury goods or medical technology companies dedicated to women’s health, there is no shortage of businesses catering to women.

7 women-focused product companies listed on NASDAQ

So sit back, grab a cup of coffee, and get ready to learn more about some of the most exciting women-focused product companies listed on NASDAQ. Whether you’re a seasoned investor or just starting out, we think you’ll find plenty of insights and inspiration in the pages that follow. Let’s get started!

Progyny Inc. (PGNY:NYSE)

Progyny is a fertility benefits management company that provides services to employers and health plans. The company’s products include fertility treatments and egg freezing.

Progyny Inc is currently traded at $34.93. Analyst consensus had rated the share as ‘Strong Buy’ with an average price target of $43.75, an 25.25% upside. Along with a with a high forecast of $48.00 and a low forecast of $34.00.

The company reported its Q4 earnings per share of $0.03 on revenue of $214.3M.

Bumble Inc. (BMBL:NYSE)

Bumble Inc. is the parent company of Bumble, Badoo, and Fruitz. The Bumble platform enables people to connect and build equitable and healthy relationships.

It’s no secret that Bumble was one of the first dating apps developed with women at its core, allowing women to take the initiative in finding their ideal romantic match when connecting with potential romantic partners.

Bumble has expanded to include features like Bumble BFF (for finding platonic friendships) and Bumble Bizz (for professional networking). The company went public in February 2021 and has since become a popular choice for women who want to take control of their online dating and social lives. In addition, the app’s focus on women’s safety and empowerment sets it apart from other dating and social networking platforms, and has helped it gain a loyal user base.

The company share is currently traded at $20.69. Analyst consensus had rated the share as ‘Moderate Buy’ with an average price target of $27.67 an 33.74% upside. Along with a with a high forecast of $35.00 and a low forecast of $20.00.

CareDx Inc. (CDNA:NYSE)

CareDx is a precision medicine company that focuses on improving the lives of patients with organ transplant. There are several products that have been developed by this company, including a test that helps identify potential organ rejection in women who have received a kidney transplant.

CareDx is currently traded at $10.61. Analyst consensus had rated the share as ‘Moderate Buy’ with an average price target of $14.80, an 39.49% upside. Along with a with a high forecast of $24.00 and a low forecast of $9.00.

Anixa Biosciences Inc. (ANIX:NYSE)

The company is a biotechnology company that develops cancer treatments and its primary product is a cancer vaccine that is designed to target ovarian cancer, one of the most prevalent cancers in women.

One of Anixa’s vaccine portfolio includes a novel vaccine being developed in collaboration with Cleveland Clinic to prevent breast cancer – specifically triple negative breast cancer (TNBC), the most lethal form of the disease – as well as a vaccine to prevent ovarian cancer.

The company share is currently traded at $4.87. Analyst consensus had rated the share as ‘Moderate Buy’ with an average price target of $9.50 an 95.07% upside. Along with a with a high forecast of $11.00 and a low forecast of $8.00

Hologic Inc. (HOLX:NYSE)

Hologic is a medical technology company that develops diagnostic and surgical products for women’s health. This company offers a variety of products, including breast imaging systems, cervical cancer screening tests, and prenatal testing products such as ThinPrep® Pap test and Aptima® HPV assays.

At the time of writing, the company shares are trading at $79.13 Analyst consensus had rated the share as ‘Moderate Buy’ with an average price target of $87.45 an 10.51% upside. Along with a with a high forecast of $95.00 and a low forecast of $75.00.

Inari Medical Inc. (NARI:NYSE)

The Inari Medical Company is a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT and PE are more common in women, making Inari’s products particularly relevant for women’s health.

Last March 5, 2023. the company announced positive results from the FLAME study in high-risk/massive pulmonary embolism (“PE”).

“The results of the trial will have an immediate impact on the treatment of high-risk PE patients and will ultimately change clinical practice guidelines for that population. Furthermore, the magnitude of the benefit seen in FLAME will undoubtably influence treatment decisions over a broader spectrum of PE patients.” – Thomas Tu, MD, Chief Medical Officer of Inari Medical.

At the time of writing, the company shares are trading at $54.64 Analyst consensus had rated the share as ‘Strong Buy’ with an average price target of $87.33 an 59.83% upside. Along with a with a high forecast of $105.00 and a low forecast of $65.00.

InMode Ltd. (INMD:NYSE)

InMode is a medical technology company that specializes in minimally invasive procedures for women’s aesthetic and wellness needs. The company’s innovative products include BodyTite (a body contouring device), FaceTite (a non-surgical facelift device), and Votiva (a radiofrequency treatment for vaginal health and rejuvenation).

The company went public in 2019 and has since become a popular choice for women who want to enhance their appearance and wellness without undergoing invasive procedures.

It also well known for minimally invasive procedures for women’s aesthetic and wellness needs meets a growing demand for non-surgical alternatives to traditional cosmetic and wellness treatments. InMode’s products offer women a safe and effective way to achieve their aesthetic and wellness goals, making it a compelling choice for women who want to look and feel their best.

Currently, shares of the company are trading at $36.06 per share. Analyst consensus had rated the share as ‘Strong Buy’ with an average price target of $51.25 an 50.47% upside. Along with a with a high forecast of $60.00 and a low forecast of $45.00

Bottom Line

By investing in companies that prioritize women’s needs and empowerment, you can not only support gender diversity and equality, but also potentially benefit from the growth and success of these innovative businesses. So why not consider adding a women-focused product company to your investment portfolio today?

The key takeaways/market update is a series by AxeHedge, which serves as an initiative to bring compact and informative In/Visible Talks recaps/takeaways on leading brands and investment events happening around the globe.

Do keep an eye out for our posts by subscribing to our channel and social media.

None of the material above or on our website is to be construed as a solicitation, recommendation or offer to buy or sell any security, financial product or instrument. Investors should carefully consider if the security and/or product is suitable for them in view of their entire investment portfolio. All investing involves risks, including the possible loss of money invested, and past performance does not guarantee future performance.

Written By

Become a AXEHEDGE investor today.

ascending